Recombinant Ostreid herpesvirus 1 Uncharacterized protein ORF47 (ORF47), partial

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder

Note: We will prioritize shipping the format currently in stock. If you require a specific format, please specify this in your order comments; we will fulfill your request to the best of our ability.

Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.

Note: All proteins are shipped with standard blue ice packs unless otherwise specified. Dry ice shipping requires prior arrangement and incurs additional charges.

Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and can be used as a guideline.
Shelf Life
Shelf life depends on several factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is recommended for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.

The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.

Synonyms
ORF47; Uncharacterized protein ORF47
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Ostreid herpesvirus 1 (isolate France) (OsHV-1) (Pacific oyster herpesvirus)
Target Names
ORF47
Uniprot No.

Q&A

What is the predicted function of Ostreid herpesvirus 1 ORF47 protein?

Based on homology with other herpesvirus proteins, OsHV-1 ORF47 is likely a serine/threonine protein kinase. In the well-studied varicella-zoster virus (VZV), the ORF47 protein functions as a serine kinase that phosphorylates regulatory viral proteins . Similar to VZV ORF47, the OsHV-1 ORF47 protein may be involved in phosphorylating viral regulatory proteins critical for viral replication and may be packaged in the tegument of viral particles.

How does recombinant OsHV-1 ORF47 compare to its natural counterpart?

Recombinant OsHV-1 ORF47 protein should theoretically maintain similar structural and functional properties as the native protein, though expression systems may affect post-translational modifications. Studies with recombinant VZV ORF47 have shown that preservation of kinase activity requires specific in vitro conditions, including physiological concentrations of polyamines . Researchers should consider that recombinant OsHV-1 ORF47 may similarly require specific conditions to maintain its biological activity in experimental settings.

What experimental approaches can verify the predicted kinase activity of OsHV-1 ORF47?

To verify kinase activity, researchers should design in vitro kinase assays with purified recombinant OsHV-1 ORF47 protein. Drawing from VZV ORF47 research, assays should include physiological concentrations of polyamines and appropriate substrates . Potential substrates may include OsHV-1 regulatory proteins similar to how VZV ORF47 phosphorylates ORF62 and ORF63 proteins. Researchers should also consider co-immunoprecipitation experiments to identify protein-protein interactions, as VZV ORF47 was found to co-precipitate with ORF63 protein .

What role might OsHV-1 ORF47 play in virus-host interactions during infection?

Drawing parallels from VZV research, OsHV-1 ORF47 likely plays a critical role in viral pathogenesis within specific host cell types. In VZV, ORF47 is essential for viral replication in human T cells and skin epithelial cells but dispensable in tissue culture . This suggests that OsHV-1 ORF47 may have cell type-specific functions within molluscan hosts, potentially being crucial for infection of certain cells while dispensable in others. Researchers should investigate whether OsHV-1 ORF47 similarly influences tissue tropism by comparing wild-type virus with ORF47-deficient mutants in different oyster cell types.

How might OsHV-1 ORF47 contribute to viral pathogenesis in bivalve mollusks?

OsHV-1 ORF47 may be a key virulence determinant in molluscan hosts. VZV studies demonstrate that ORF47 is required for replication in differentiated human cells that are essential targets for pathogenesis in vivo, while being dispensable in vitro . Similarly, OsHV-1 ORF47 might be essential for replication in specific oyster cell types critical for disease progression. Researchers should develop ORF47-deficient OsHV-1 mutants and evaluate their replication capacity in different oyster tissues to determine its role in pathogenesis.

What cellular and viral proteins might interact with OsHV-1 ORF47?

Based on VZV ORF47 studies, potential interaction partners for OsHV-1 ORF47 could include:

  • Viral regulatory proteins equivalent to VZV ORF62 and ORF63, which are phosphorylated by VZV ORF47

  • Viral envelope glycoproteins, as VZV ORF47 may phosphorylate glycoprotein E

  • Host cellular proteins involved in protein synthesis, similar to how HSV-1 UL13 (homolog of VZV ORF47) hyperphosphorylates elongation factor 1δ

Researchers should employ co-immunoprecipitation, yeast two-hybrid systems, or proximity ligation assays to identify these potential interactions.

What are the optimal conditions for preserving recombinant OsHV-1 ORF47 kinase activity?

Based on findings with VZV ORF47, researchers should consider the following conditions:

  • Inclusion of physiological concentrations of polyamines in enzyme assays

  • Temperature conditions mimicking the natural host environment of oysters (lower than mammalian 37°C)

  • Appropriate pH and salt concentrations relevant to mollusk cellular environments

  • Presence of proper cofactors such as ATP and divalent cations (Mg²⁺, Mn²⁺)

The VZV research demonstrated that "preservation of the intrinsic kinase activity of recombinant VZV ORF47 required unusually stringent in vitro conditions," suggesting that similar considerations may be crucial for OsHV-1 ORF47 .

How can researchers effectively generate and validate ORF47-deficient OsHV-1 mutants?

To study ORF47 function through loss-of-function approaches, researchers should:

  • Generate ORF47-deficient mutants using techniques similar to those used for VZV, such as inserting stop codons early in the ORF47 coding sequence

  • Create a complemented strain by inserting the intact ORF47 gene at a distant, non-coding site in the viral genome to verify phenotype specificity

  • Confirm mutant construction by PCR amplification and sequencing of relevant genomic regions

  • Verify protein expression patterns using Western blot analysis

Researchers should also develop cell culture systems permissive for OsHV-1 replication to facilitate these genetic studies.

What in vivo models are suitable for studying OsHV-1 ORF47 function?

For studying OsHV-1 ORF47 function in vivo, researchers should consider:

  • Laboratory-controlled infections in susceptible oyster species (Crassostrea gigas)

  • Infection of specific oyster tissues or primary cell cultures derived from relevant tissues

  • Development of a system analogous to the SCID-hu mouse model used for VZV, which allowed study of viral replication in human tissue implants

The experimental design should include:

Experimental GroupDescriptionKey Measurements
Wild-type OsHV-1Control groupViral replication kinetics, protein expression, tissue distribution
ORF47-deficient OsHV-1Test groupComparative replication capacity, protein expression patterns
Complemented ORF47 mutantVerification groupRestoration of wild-type phenotype
Mock-infectedNegative controlBaseline measurements

How can researchers differentiate between direct and indirect effects of OsHV-1 ORF47?

Differentiating direct and indirect effects of OsHV-1 ORF47 requires multiple complementary approaches:

  • In vitro kinase assays with purified components to identify direct phosphorylation targets

  • Phosphoproteomics comparing wild-type and ORF47-deficient virus-infected cells

  • Temporal analysis of phosphorylation events during infection

  • Site-directed mutagenesis of the kinase active site to create catalytically inactive ORF47

Researchers should consider that in VZV, the ORF47 protein enters the cell with the virus as part of the tegument, suggesting immediate early effects distinct from later gene expression effects .

What potential compensatory mechanisms might mask OsHV-1 ORF47 functions in experimental settings?

The VZV research provides important insights into potential compensatory mechanisms that could mask OsHV-1 ORF47 functions:

  • Cellular kinases may compensate for ORF47 function in certain cell types but not others, explaining why VZV ORF47 is dispensable in tissue culture but essential in differentiated human cells

  • Other viral kinases may partially compensate for ORF47 function, as suggested by the observation that VZV ORF66 (another viral kinase) could not fully compensate for ORF47 deficiency

  • High levels of cellular casein kinase II (CKII) in cultured cells may compensate for ORF47 absence, as CKII can phosphorylate some of the same substrates

Researchers should design experiments to account for these potential compensatory mechanisms.

How should researchers address apparent contradictions between in vitro and in vivo findings?

Based on the VZV ORF47 research, researchers studying OsHV-1 ORF47 should anticipate potential contradictions between in vitro and in vivo findings . Strategies to address these contradictions include:

  • Using multiple cell types and culture conditions that better represent the in vivo environment

  • Developing organotypic culture systems that maintain the differentiated state of mollusk tissues

  • Performing comprehensive in vivo experiments with appropriate controls

  • Analyzing gene expression and protein modifications in both settings to identify differences

The VZV research demonstrated that "this gene product, which is dispensable in vitro, has a critical role within differentiated cells that are essential targets for VZV pathogenesis in vivo," highlighting the importance of in vivo verification .

What emerging technologies might advance OsHV-1 ORF47 research?

Several cutting-edge technologies could significantly advance OsHV-1 ORF47 research:

  • CRISPR-Cas9 genome editing for more precise genetic manipulation of OsHV-1

  • Single-cell transcriptomics and proteomics to understand cell type-specific effects of ORF47

  • Cryo-electron microscopy for structural determination of ORF47 alone and in complex with substrates

  • Phosphoproteomics to identify the complete set of ORF47 substrates during infection

  • Oyster cell and tissue culture systems that better mimic the in vivo environment

These technologies could help overcome current limitations in studying OsHV-1 pathogenesis in molluscan hosts.

How might structure-function studies of OsHV-1 ORF47 inform antiviral development?

Structure-function studies of OsHV-1 ORF47 could lead to the development of specific kinase inhibitors as potential antivirals. Researchers should:

  • Determine the crystal structure of OsHV-1 ORF47 kinase domain

  • Identify key catalytic residues through site-directed mutagenesis

  • Perform in silico screening for potential inhibitors targeting the ATP-binding pocket

  • Validate candidate inhibitors using in vitro kinase assays and viral replication studies

The essential nature of ORF47 for VZV replication in specific cell types suggests that targeting its OsHV-1 homolog could be an effective antiviral strategy for protecting oyster populations .

What broader implications does OsHV-1 ORF47 research have for understanding herpesvirus evolution?

OsHV-1 ORF47 research could provide valuable insights into herpesvirus evolution across different host species:

  • Comparative analysis of protein kinase conservation between vertebrate and invertebrate herpesviruses

  • Evaluation of substrate specificity evolution across diverse herpesvirus kinases

  • Analysis of how kinase functions adapted to different host cellular environments

  • Assessment of how essential these kinases are for viral replication across different evolutionary lineages

The high conservation of viral kinases throughout herpesvirus evolution, as noted in the VZV studies, suggests these proteins serve fundamental roles in viral replication strategies across diverse hosts .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.